Item 14
0.01 kg of a radioactive ligand probe with a half life of 6 hours and atomic mass of 96 g/mol is injected into a 90 kg patient. Each decay delivers a 3 meV α particla.
Part A - What is the equivalent dose received by the patient after all of the probe has decayed?
Dose equivalent = 350 mSv
Dose equivalent = 2.59 Sv
Dose equivalent = 6.69 Sv
Dose equivalent = 1.75 Sv
Dose equivalent = 130 mSv
Dose equivalent = 648 mSv
number of moles of radioactive ligand probe = 10/96 = 0.10416
number of molecules present in 0.10416 moles = 0.10416*6.023*10^23
= 6.273*10^22
since each deacy delivers a 3meV alpha particle
So total energy delivered by all the decays = 3meV * 6.273*10^22
= 1.88218*10^29 eV
= 3.015*10^10 joules
1 Sv = 1 joule/kilogram
Dose equivalent = 3.015*10^10 joules / 90 kg
= 350 mSv
Item 14 0.01 kg of a radioactive ligand probe with a half life of 6 hours...
A 95 kg patient swallows a 34 ?Ci beta emitter whose half-life is 5.0 days and whose RBE is 1.6. The beta particles are emitted with an average energy of 0.35 MeV, 90% of which is absorbed by the body. You are a health care worker needing to find the patient's dose equivalent after one week. These series of steps will help you find that dose equivalent. In all questions, assume the radioactive nuclei are distributed throughout the patient's body...
(1) Fluorine-18 fluorodeoxyglucose (18FDG) is a radioactive tracer (half life of 1.83 hours) administered to patients who are undergoing PET imaging. This imaging modality, which creates images by detecting the positrons that are emitted when the fluorine-18 undergoes 8+ decay, permits physicians to monitor the metabolism of glucose in the body (a) Write down the decay chain for fluorine-18 when it undergoes β+ decay (b) A patient is given a dose of 18FDG prior to a PET scan to monitor...